Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Pfizer Inc N.PFE


Primary Symbol: PFE

Healthcare
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:PFE)

Pfizer Announces New Chief Scientific Officer and President, Research & Development

Business Wire 1 day ago

European Commission Approves Pfizer's HYMPAVZI(TM) (marstacimab) for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without Inhibitors

Business Wire 1 day ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Business Wire 7 days ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Business Wire November 4, 2024

Pfizer Reports Strong Third-Quarter 2024 Results And Raises 2024 Guidance

Business Wire October 29, 2024

Advisory Committee on Immunization Practices Recommends PREVNAR 20® (20-Valent Pneumococcal Conjugate Vaccine) for Adults Aged 50 and Older

Business Wire October 23, 2024

U.S. FDA Approves Pfizer's RSV Vaccine ABRYSVO® for Adults Aged 18 to 59 at Increased Risk for Disease

Business Wire October 22, 2024

Tim Buckley Elected to Pfizer's Board of Directors

Business Wire October 15, 2024

U.S. FDA Approves Pfizer's HYMPAVZI(TM) (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors

Business Wire October 11, 2024
View More News ››

Opinion & Analysis (NYSE:PFE)

BioNTech, Eastman Kodak, EXMceuticals - investors have the chance to profit

Stockhouse Editorial July 29, 2020

BioNTech, Evotec, EXMceuticals - which stocks have the potential to double?

Stockhouse Editorial June 18, 2020

Buzz on the Bullboards: HOT Coronavirus Healthcare Stocks

Omri Wallach March 19, 2020

Mylan Gets a Shot in the Arm with Pfizer Merger Deal

Streetwise Reports July 31, 2019

Sangamo and Pfizer Report Positive Results for Hemophilia A Study

Streetwise Reports July 9, 2019

The ProMIS of an Alzheimer's cure

The Life Sciences Report May 4, 2017
View More Opinion ››

Bullboard Posts (NYSE:PFE)

Way oversold

Just over reaction at the moment. It generates money and there is too many projects on the table. glta dyodd
ecolo101 - 2 days ago

RE:Maybe $25

Just a question,  If you buy PFE on the Canadian NEO exchange, are you still eligible to receive dividends? and in US $$.  If...
ozkan123 - 6 days ago

Well! It happens

Kennedy Junior got the head of the health department....ouch Just Watch him over the next year, hopefully somebody can find a best...
ecolo101 - 6 days ago

Ex dividend date

Tomorrow, so today was the day to get in. Dividend 6.12% annually so $1.68 or $0.42 per quarter. big pharma seems to be waiting to...
ecolo101 - November 7, 2024

Maybe $25

Wait wait wait forget the dividend if it goes to a lower entrance point. dyodd
ecolo101 - November 4, 2024

Ex dividend date coming soon

November 8th and if you are registered you will be eligible to $0.42 , not bad at all in a declining interest rate environment... glta...
ecolo101 - November 1, 2024
View more Bullboard ››

Cascadia Minerals Ltd

Cascadia Minerals Ltd

Cascadia is a Canadian junior mining company focused on exploring for copper and gold in the Yukon and British Columbia ...
View More »